Deutsche Bank
XFOR icon

Deutsche Bank’s X4 Pharmaceuticals XFOR Stock Holding History

Deutsche Bank’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,921
Closed -$64.2K – 3757
2025
Q1 		$64.2K Hold
8,921
– – ﹤0.01% 3322
2024
Q4 		$195K Buy
8,921
+7,568
+559% +$121K ﹤0.01% 3101
2024
Q3 		$27.2K Hold
1,353
– – ﹤0.01% 3450
2024
Q2 		$23.5K Sell
1,353
-407
-23% -$13.3K ﹤0.01% 3417
2024
Q1 		$73.4K Buy
+1,760
New +$49K ﹤0.01% 3284
2023
Q4 		– Sell
-2,041
Closed -$66.7K – 3713
2023
Q3 		$66.7K Hold
2,041
– – ﹤0.01% 3336
2023
Q2 		$119K Buy
+2,041
New +$105K ﹤0.01% 3194
2021
Q2 		– Sell
-348
Closed -$90K – 4825
2021
Q1 		$90K Sell
348
-32
-8% -$8.41K ﹤0.01% 4034
2020
Q4 		$73K Buy
380
+108
+40% +$21.2K ﹤0.01% 4004
2020
Q3 		$55K Buy
272
+19
+8% +$4.55K ﹤0.01% 3844
2020
Q2 		$71K Buy
253
+67
+36% +$18.3K ﹤0.01% 3634
2020
Q1 		$56K Sell
186
-62
-25% -$17.6K ﹤0.01% 3491
2019
Q4 		$78K Buy
248
+120
+94% +$43K ﹤0.01% 3705
2019
Q3 		$47K Sell
128
-48
-27% -$19K ﹤0.01% 3968
2019
Q2 		$78K Buy
176
+41
+30% +$20.8K ﹤0.01% 4330
2019
Q1 		$69K Buy
135
+99
+275% +$54.6K ﹤0.01% 4454
2018
Q4 		$14K Sell
36
-30
-45% -$11.4K ﹤0.01% 4822
2018
Q3 		$19K Buy
66
+17
+35% +$7.21K ﹤0.01% 4949
2018
Q2 		$32K Buy
49
+11
+29% +$36K ﹤0.01% 4901
2018
Q1 		$155K Buy
+38
New +$111K ﹤0.01% 4316

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank's XFOR Position: Q2 2025 in Review

Deutsche Bank sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 8,921 shares — an estimated $64.2K sold.

Deutsche Bank first reported a position in XFOR in Q1 2018 and held it in 20 quarters. The position peaked at $195K in Q4 2024. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

  • Deutsche Bank reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 8,921 X4 Pharmaceuticals shares in Q2 2025, an estimated $64.2K.
  • Deutsche Bank first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 20 quarters.
  • Deutsche Bank's X4 Pharmaceuticals position peaked at $195K in Q4 2024.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.